NHS Breast Screening multidisciplinary working group guidelines for the diagnosis and management of breast lesions of uncertain malignant potential on core biopsy (B3 lesions)

Clinical Radiology - Tập 73 Số 8 - Trang 682-692 - 2018
Sarah E. Pinder1, Abeer M. Shaaban2, Rahul Deb3, Archita P. Desai4, Ashu Gandhi5, A.H.S. Lee6, Stéphanie Pain7, L Wilkinson8, Nisha Sharma9
1Department of Breast Pathology, King's College London, Guy's Hospital, London SE1 9RT, UK
2Department of Histopathology, University Hospitals Birmingham NHS Foundation Trust, Mindelsohn Way, Birmingham B15 2WB, UK
3Department of Histopathology, Royal Derby Hospital, Uttoxeter New Road, Derby DE22 3NE, UK
4Department of Oncoplastic and Reconstructive Breast Surgery, Breast Care, Chartwell Unit, Princess Royal University Hospital, Farnborough Common, Kent BR6 8ND, UK
5Department of Breast & Endocrine Surgery, University Hospital of South Manchester, Manchester M23 9LT, UK
6Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham NG5 1PB, UK
7Department of Surgery, Norfolk and Norwich University Hospital, Colney Lane, Norwich NR4 7UY, UK
8Department of Radiology, St George's Hospital, Blackshaw Road, Tooting, London SW17 0BZ, UK
9Department of Radiology, Breast Unit, Level 1 Chancellor Wing, St James Hospital, Leeds LS9 7TF, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Bianchi, 2011, Positive predictive value for malignancy on surgical excision of breast lesions of uncertain malignant potential (B3) diagnosed by stereotactic vacuum-assisted needle core biopsy (VANCB): a large multi-institutional study in Italy, Breast, 20, 264, 10.1016/j.breast.2010.12.003

El-Sayed, 2008, Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening, Histopathology, 53, 650, 10.1111/j.1365-2559.2008.03158.x

Maclean, 2013, Is mode of presentation of B3 breast core biopsies (screen-detected or symptomatic) a distinguishing factor in the final histopathologic result or risk of diagnosis of malignancy?, World J Surg, 37, 2607, 10.1007/s00268-013-2191-6

Lee, 2016, Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening, Royal Coll Pathol

Rakha, 2011, Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening, Int J Canc, 129, 1417, 10.1002/ijc.25801

Yu, 2010, Diagnostic value of vacuum-assisted breast biopsy for breast carcinoma: a meta-analysis and systematic review, Breast Canc Res Treat, 120, 469, 10.1007/s10549-010-0750-1

Canas-Marques, 2016, E-cadherin immunohistochemistry in breast pathology: uses and pitfalls, Histopathology, 68, 57, 10.1111/his.12869

Carder, 2010, Screen-detected pleomorphic lobular carcinoma in situ (PLCIS): risk of concurrent invasive malignancy following a core biopsy diagnosis, Histopathology, 57, 472, 10.1111/j.1365-2559.2010.03634.x

Menon, 2008, The significance of lobular neoplasia on needle core biopsy of the breast, Virchows Arch, 452, 473, 10.1007/s00428-008-0607-8

Buckley, 2014, A systematic review of surgical biopsy for LCIS found at core needle biopsy — do we have the answer yet?, Eur J Surg Oncol, 40, 168, 10.1016/j.ejso.2013.10.024

Hussain, 2011, Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast—a review, Eur J Surg Oncol, 37, 279, 10.1016/j.ejso.2011.01.009

Hwang, 2008, Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary, Mod Pathol, 21, 1208, 10.1038/modpathol.2008.134

Murray, 2013, Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision, Cancer, 119, 1073, 10.1002/cncr.27841

Fraser, 1998, Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications, Am J Surg Pathol, 22, 1521, 10.1097/00000478-199812000-00009

Verschuur-Maes, 2012, Columnar cell lesions on breast needle biopsies: is surgical excision necessary? A systematic review, Ann Surg, 255, 259, 10.1097/SLA.0b013e318233523f

Jackman, 1999, Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up, Radiology, 210, 799, 10.1148/radiology.210.3.r99mr19799

Brenner, 2002, Percutaneous core needle biopsy of radial scars of the breast: when is excision necessary?, AJR Am J Roentgenol, 179, 1179, 10.2214/ajr.179.5.1791179

Donaldson, 2016, Calhoun BC. Radial scars diagnosed on breast core biopsy: frequency of atypia and carcinoma on excision and implications for management, Breast, 10.1016/j.breast.2016.06.007

Li, 2016, Pathologic findings of follow-up surgical excision for radial scar on breast core needle biopsy, Hum Pathol, 48, 76, 10.1016/j.humpath.2015.06.028

Page, 1996, Subsequent breast carcinoma risk after biopsy with atypia in a breast papilloma, Cancer, 78, 258, 10.1002/(SICI)1097-0142(19960715)78:2<258::AID-CNCR11>3.0.CO;2-V

Eiada, 2012, Papillary lesions of the breast: MRI, ultrasound, and mammographic appearances, AJR Am J Roentgenol, 198, 264, 10.2214/AJR.11.7922

Bianchi, 2015, Non-malignant breast papillary lesions—B3 diagnosed on ultrasound-guided 14-gauge needle core biopsy: analysis of 114 cases from a single institution and review of the literature, Pathol Oncol Res, 21, 535, 10.1007/s12253-014-9882-7

Wiratkapun, 2014, Fibroadenoma versus phylloides tumor: distinguishing factors in patients diagnosed with fibroepithelial lesions after a core needle biopsy, Diagn Interv Radiol, 20, 27

Evans, 1998, Phylloides tumour, 69

Abdulcadir, 2014, Phylloides tumours of the breast diagnosed as B3 category on image-guided 14-gauge core biopsy: analysis of 51 cases from a single institution and review of the literature, Eur J Surg Oncol, 40, 859, 10.1016/j.ejso.2014.02.222

Rakha, 2011, Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia, Histopathology, 58, 626, 10.1111/j.1365-2559.2011.03786.x

Rakha, 2013, Outcome of pure mucocele-like lesions diagnosed on breast core biopsy, Histopathology, 62, 894, 10.1111/his.12081

Association of Breast Surgery at BASO, 2009, Quality assurance guidelines for surgeons in breast cancer screening

The Royal College of Radiologists, 2012

Huber, 2003, Benign breast lesions: minimally invasive vacuum-assisted biopsy with 11-gauge needles—patient acceptance and effect on follow-up imaging findings, Radiology, 226, 783, 10.1148/radiol.2271011933

Abdel-Fatah, 2007, High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma, Am J Surg Pathol, 31, 417, 10.1097/01.pas.0000213368.41251.b9

Rajan, 2012, New patient pathway using vacuum-assisted biopsy reduces diagnostic surgery for B3 lesions, Clin Radiol, 67, 244, 10.1016/j.crad.2011.09.002

Pieri, 2015, Vacuum-assisted biopsy is a viable alternative to surgical biopsy in the investigation of breast lesions of uncertain malignant potential, Surgeon

Strachan, 2016, Outcome of a new patient pathway for managing B3 breast lesions by vacuum-assisted biopsy: time to change current UK practice?, J Clin Pathol, 69, 248, 10.1136/jclinpath-2015-203018

Preibsch, 2015, Vacuum-assisted breast biopsy with 7-gauge, 8-gauge, 9-gauge, 10-gauge, and 11-gauge needles: how many specimens are necessary?, Acta Radiol, 56, 1078, 10.1177/0284185114549224